Genetic Testing Unravels Unusual Patterns for Fragile-X Syndrome
|
By LabMedica International staff writers Posted on 11 Dec 2017 |

Image: Karyotyping of patient with Klinefelter syndrome, a chromosomal condition that affects male physical and cognitive development. Its signs and symptoms vary among affected individuals. This male has an extra X chromosome (Photo courtesy of Wellcome Trust).
Fragile-X syndrome is an X-linked disorder with a prevalence of about 1 in 3,600 to 4,000 in males and 1 in 4,000 to 6,000 in females and is the main cause of inherited intellectual disability (ID) and cognitive impairment.
Fragile-X syndrome (FXS) is a rare disease and ID is frequently associated with chromosomal imbalances that often involve the X chromosome, and most clinicians primarily request molecular diagnosis of FXS for patients affected by any type of ID or developmental delay.
Scientists at the University of Naples Federico II (Naples, Italy) and their colleagues studied three women affected by intellectual/psychomotor delay and primary or secondary amenorrhea, and six men affected by mental retardation or psychomotor delay. The enrollees underwent FXS molecular diagnosis and resulted to have normal CGG triplets in the Fragile X Mental Retardation 1 (FMR1) gene, but showed atypical X chromosome patterns. Further diagnostic investigations and, in two females, array-comparative genomic hybridization (array-CGH) revealed the possible genetic cause of their conditions.
The team extracted DNA from 10 mL of whole blood samples from each subject and the CGG repeat number of FMR1 alleles up to 160 CGG repeats was determined by capillary gel electrophoresis of fluorescent-labeled DNA amplicons using primers F (labeled with NED fluorochrome) and C. The triplet repeat primed polymerase chain reaction (TP-PCR) and the Southern blot analysis of genomic DNA digested with restriction enzymes were performed. The X-inactivation analysis was carried out with the PCR-based method for methylation-dependent amplification of the polymorphic triplet repeats at the human androgen receptor (HUMARA) gene. Amplification products were separated by capillary gel electrophoresis on the ABI Prism 3130 genetic analyzer.
The investigators reported that six men affected by ID and three women affected by ID and fragile X-associated premature ovarian failure/ primary ovarian insufficiency (POF/POI) underwent FXS molecular testing. They had normal FMR1 CGG repeats, but atypical X chromosome patterns. Further investigations revealed that the six males had Klinefelter syndrome (XXY), one female was a Turner mosaic (X0/XX) and two women had novel rearrangements involving X chromosome.
The authors concluded that diagnostic investigation of atypical patterns at FMR1 locus can address patients and/or their relatives to further verify the condition by performing karyotyping and/or array-CGH. They emphasize that, for all the presented patients, their diagnostic report concluded for the absence of pathological expansion in the FMR1 gene and the presence of analytical findings that were suggestive of X chromosome abnormality. The study was published online on November 21, 2017, in the journal Clinica Chimica Acta.
Related Links:
University of Naples Federico II
Fragile-X syndrome (FXS) is a rare disease and ID is frequently associated with chromosomal imbalances that often involve the X chromosome, and most clinicians primarily request molecular diagnosis of FXS for patients affected by any type of ID or developmental delay.
Scientists at the University of Naples Federico II (Naples, Italy) and their colleagues studied three women affected by intellectual/psychomotor delay and primary or secondary amenorrhea, and six men affected by mental retardation or psychomotor delay. The enrollees underwent FXS molecular diagnosis and resulted to have normal CGG triplets in the Fragile X Mental Retardation 1 (FMR1) gene, but showed atypical X chromosome patterns. Further diagnostic investigations and, in two females, array-comparative genomic hybridization (array-CGH) revealed the possible genetic cause of their conditions.
The team extracted DNA from 10 mL of whole blood samples from each subject and the CGG repeat number of FMR1 alleles up to 160 CGG repeats was determined by capillary gel electrophoresis of fluorescent-labeled DNA amplicons using primers F (labeled with NED fluorochrome) and C. The triplet repeat primed polymerase chain reaction (TP-PCR) and the Southern blot analysis of genomic DNA digested with restriction enzymes were performed. The X-inactivation analysis was carried out with the PCR-based method for methylation-dependent amplification of the polymorphic triplet repeats at the human androgen receptor (HUMARA) gene. Amplification products were separated by capillary gel electrophoresis on the ABI Prism 3130 genetic analyzer.
The investigators reported that six men affected by ID and three women affected by ID and fragile X-associated premature ovarian failure/ primary ovarian insufficiency (POF/POI) underwent FXS molecular testing. They had normal FMR1 CGG repeats, but atypical X chromosome patterns. Further investigations revealed that the six males had Klinefelter syndrome (XXY), one female was a Turner mosaic (X0/XX) and two women had novel rearrangements involving X chromosome.
The authors concluded that diagnostic investigation of atypical patterns at FMR1 locus can address patients and/or their relatives to further verify the condition by performing karyotyping and/or array-CGH. They emphasize that, for all the presented patients, their diagnostic report concluded for the absence of pathological expansion in the FMR1 gene and the presence of analytical findings that were suggestive of X chromosome abnormality. The study was published online on November 21, 2017, in the journal Clinica Chimica Acta.
Related Links:
University of Naples Federico II
Latest Molecular Diagnostics News
- Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
- Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
- Genetic Marker to Help Children with T-Cell Leukemia Avoid Unnecessary Chemotherapy
- Four-Gene Blood Test Rules Out Bacterial Lung Infection
- New PCR Test Improves Diagnostic Accuracy of Bacterial Vaginosis and Candida Vaginitis
- New Serum Marker-Editing Strategy to Improve Diagnosis of Neurological Diseases
- World’s First Genetic Type 1 Diabetes Risk Test Enables Early Detection
- Blood Test to Help Low-Risk Gastric Cancer Patients Avoid Unnecessary Surgery
- First-Of-Its-Kind Automated System Speeds Myeloma Diagnosis
- Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention
- First Of Its Kind Blood Test Detects Gastric Cancer in Asymptomatic Patients
- Portable Molecular Test Detects STIs at POC in 15 Minutes
- Benchtop Analyzer Runs Chemistries, Immunoassays and Hematology in Single Device
- POC Bordetella Test Delivers PCR-Accurate Results in 15 Minutes
- Pinprick Blood Test Could Detect Disease 10 Years Before Symptoms Appear
- Refined C-Reactive Protein Cutoffs Help Assess Sepsis Risk in Preterm Babies
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more




 assay.jpg)



